Colonization With Levofloxacin-resistant Extended-spectrum β-Lactamase-producing Enterobacteriaceae and Risk of Bacteremia in Hematopoietic Stem Cell Transplant Recipients.,Clinical Infectious Diseases

当前位置： X-MOL 学术 › Clin. Infect. Dis. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Colonization With Levofloxacin-resistant Extended-spectrum β-Lactamase-producing Enterobacteriaceae and Risk of Bacteremia in Hematopoietic Stem Cell Transplant Recipients.
Clinical Infectious Diseases ( IF 11.8 ) Pub Date : 2018-04-26 , DOI: 10.1093/cid/ciy363
Michael J Satlin ₁ , Kalyan D Chavda ₂ , Thomas M Baker _{1,

3} , Liang Chen ₂ , Elena Shashkina ₂ , Rosemary Soave ₁ , Catherine B Small ₁ , Samantha E Jacobs _{1,

4} , Tsiporah B Shore ₅ , Koen van Besien ₅ , Lars F Westblade _{1,

6} , Audrey N Schuetz _{1,

6,

7} , Vance G Fowler ₈ , Stephen G Jenkins _{1,

6} , Thomas J Walsh _{1,

9} , Barry N Kreiswirth ₂

Affiliation

Bacteremia caused by extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae (ESBL-E) is associated with inadequate empirical therapy and substantial mortality in neutropenic patients. Strategies are needed to identify neutropenic patients at high risk of these infections.

中文翻译：